CVS Caremark Corp (NYSE:CVS) Big Money Sentiment Change at 0.72

May 16, 2018 - By Joshua Cleveland

CVS Health Corporation (NYSE:CVS) Corporate Logo

CVS Caremark Corp’s Sentiment

“Big money sentiment for CVS Caremark Corp (NYSE:CVS) in 2017 Q4 decreased to 0.72, SEC filings reveal. So its down -0.16, from 2017Q3’s 0.88. 514 institutional investors increased and opened new holdings, while 715 reduced and sold their holdings in CVS Caremark Corp so the sentiment fall. These funds own 815.59 million shares, that’s up from 801.45 million shares in 2017Q3. Funds holding CVS Caremark Corp in top 10 decreased from 59 to 30 for a decrease of 29. In total 115 funds closed positions, 600 reduced and 380 increased. Also 134 funds bought new CVS Caremark Corp stakes.

Significant CVS Caremark Corp Shareholders

As of 2017 Q4 Veritas Investment Management Llp has 7.22% invested in CVS Caremark Corp. CVS Caremark Corp’s shareholder Cortland Associates Inc Mo owns 513,230 shares as of 2017 Q4. St. James Investment Company Llc reported 786,377 shares. Veritas Asset Management Llp revealed 11.68 million shares position in CVS Caremark Corp. The New York-based fund Senzar Asset Management Llc looks positive on CVS Caremark Corp, owning 315,500 shares.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services.The firm is valued at $67.22 billion. It operates through Pharmacy Services and Retail/LTC divisions.The P/E ratio is 10.26. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

CVS hit $66.12 during the last trading session after $0.28 change.CVS Health Corporation has volume of 3.94M shares. Since May 16, 2017 CVS has declined 22.81% and is downtrending. CVS underperformed the S&P 500 by 34.36%.

CVS Health Corporation (NYSE:CVS)’s quarterly earnings will be announced on August, 14., according to Zacks. earnings per share of $1.61 is 21.05 % up from 2017’s $1.33 EPS. CVS’s profit could be $1.64 billion with 10.27 P/E in case $1.61 earnings per share is announced. Last quarter $1.48 earnings per share was reported. Analysts forecasts 8.78 % EPS growth this quarter.

Allsquare Wealth Limited Liability Corporation owns 590 shs. 16,577 are owned by Blue Fincl. Bnp Paribas Asset Sa has 543,829 shs for 0.34% of their capital. Wms Prtnrs Llc owns 7,817 shs. Raab & Moskowitz Asset Ltd Llc reported 22,821 shs or 0.8% of all its holdings. Timber Hill Ltd Llc invested 0.05% in CVS Health Corporation (NYSE:CVS). Webster National Bank N A owns 73,118 shs. Endurant Cap Mgmt L P invested in 53,300 shs or 1.18% of the stock. The Minnesota-based Ameriprise Fincl has invested 0.35% in CVS Health Corporation (NYSE:CVS). Evanston Invs Dba Evanston Advisors has invested 1.8% in CVS Health Corporation (NYSE:CVS). Hexavest reported 1.1% in CVS Health Corporation (NYSE:CVS). Gotham Asset Mgmt Limited Com holds 951,796 shs or 1% of its capital. Conning invested 0.98% in CVS Health Corporation (NYSE:CVS). Cibc Asset Mgmt reported 0.04% in CVS Health Corporation (NYSE:CVS). Thrivent Fin For Lutherans invested 0.34% in CVS Health Corporation (NYSE:CVS).

CVS Health Corporation had 1 sale and 2 insider purchases since February 16, 2018. This’s net activity of $713,454. 10,000 shs were bought by BROWN C DAVID II, worth $619,900 on Friday, May 4. The insider DORMAN DAVID W bought 24,300 shs worth $1.51M.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

In total 13 analysts cover CVS Health (NYSE:CVS). “Buy” rating has 11, “Sell” are 0, while 2 are “Hold”. (NYSE:CVS) has 85% bullish analysts. 25 are the (NYSE:CVS)’s ratings reports on 16 May 2018 according to StockzIntelligence Inc. The company rating was maintained by Needham on Monday, December 4. On Monday, January 8 the company was maintained by Leerink Swann. On Tuesday, December 26 the stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given by Tigress Financial. On Thursday, February 8 the company was maintained by Robert W. Baird. On Wednesday, January 24 the company was maintained by Mizuho. In Thursday, January 4 report Robert W. Baird maintained it with “Hold” rating and $81.0 target. On Friday, January 5 the rating was upgraded by Morgan Stanley to “Overweight”. The company rating was maintained by Leerink Swann on Friday, February 9. On Wednesday, April 11 the stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Bank of America. On Thursday, January 4 the stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Raymond James.

For more CVS Health Corporation (NYSE:CVS) news brought out briefly go to: Seekingalpha.com, Seekingalpha.com, Streetinsider.com, Bizjournals.com or Seekingalpha.com. The titles are as follows: “Trade Mistake 3: CVS Boredom Trade” brought out on May 09, 2018, “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” on April 26, 2018, “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” with a publish date: May 15, 2018, “Moody’s likes the upward financial trend at this Lakeland pharmacy benefits manager” and the last “We Are Playing The CVS Hand” with publication date: May 11, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.